KRM Ayurveda
KRMAYURVED NSE
KRM Ayurveda
HealthcareNSE: KRMAYURVED Pharmaceuticals
Key Fundamentals
SMEPharmaceuticalsHealthcareMarket Cap
₹629 Cr
Volatility
Moderate
P/E Ratio
0
EBITDA
₹30.50 Cr
Return on Equity
50.67%
Debt to Equity
1.28
Book Value
₹56.55
52W High
₹343.95
52W Low
₹156.15
Tapetide Score
Data-driven rating, 0–100. How it works →
Growth Rate
Revenue Growth
32.24% higher than
3Y
Net Income Growth
64.13% lower than
3Y
Cash Flow Change
96.63% higher than
3Y
ROE
74.91% higher than
3Y
ROCE
108% higher than
3Y
EBITDA Margin (Avg.)
17.59% lower than
3Y
Quarterly Results
| Particulars | Sep 2025 |
|---|---|
| Sales | 48 |
| Expenses | 36 |
| Operating Profit | 13 |
| OPM % | 27% |
| Other Income | 0 |
| Interest | 2 |
| Depreciation | 1 |
| PBT | 11 |
| Tax % | 26% |
| Net Profit | 8 |
| EPS in Rs | 5.24 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Sales | 89 | 67 | 77 |
| Expenses | 78 | 60 | 57 |
| Operating Profit | 11 | 8 | 19 |
| OPM % | 13% | 11% | 25% |
| Other Income | 0 | 0 | 0 |
| Interest | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 |
| PBT | 10 | 5 | 16 |
| Tax % | 25% | 28% | 26% |
| Net Profit | 8 | 3 | 12 |
| EPS in Rs | 5,067 | 2,273 | 807 |
| Div. Payout % | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|
| Equity Capital | 0.15 | 0.15 | 0.15 | 16 |
| Reserves | 8 | 12 | 24 | 21 |
| Borrowings | 20 | 23 | 31 | 25 |
| Other Liabilities | 11 | 9 | 12 | 17 |
| Total Liabilities | 39 | 44 | 67 | 78 |
| Fixed Assets | 23 | 23 | 27 | 27 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Other Assets | 16 | 21 | 40 | 52 |
| Total Assets | 39 | 44 | 67 | 78 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Operating | 4 | -1 | 0 |
| Investing | -23 | 0 | -4 |
| Financing | 19 | 1 | 6 |
| Net Cash Flow | 0 | 0 | 2 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|
| Debtor Days | 32 | 30 | 58 |
| Inventory Days | 13 | 53 | 296 |
| Days Payable | 100 | 141 | 205 |
| Cash Conversion Cycle | -55 | -58 | 149 |
| Working Capital Days | 9 | 48 | 64 |
| ROCE % | — | 22% | 42% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view KRM Ayurveda insights
28 extracted metrics + investor summaries across FY23–FY25.
Documents
1
Reply to Clarification- Financial results
27 July 2026 - KRM Ayurveda filed missing FY26 financial result clarifications, working capital certificate, and unmodified audit opinion. 27 July 2026 - KRM Ayurveda filed missing FY26 financial result clarifications, working capital certificate, and unmodified audit opinion.
2
Analysts/Institutional Investor Meet/Con. Call Updates
22 July 2026 - KRM Ayurveda disclosed outcome of a virtual analyst/investor group meet on July 24, 2026. 22 July 2026 - KRM Ayurveda disclosed outcome of a virtual analyst/investor group meet on July 24, 2026.
3
Updates
20 July 2026 - Board approved sale of non-operational Delhi property for about ₹3.5 crore on 20 July 2026. 20 July 2026 - Board approved sale of non-operational Delhi property for about ₹3.5 crore on 20 July 2026.
4
Analysts/Institutional Investor Meet/Con. Call Updates
16 July 2026 - KRM Ayurveda scheduled an investor/analysts group meeting on July 20, 2026 at 4:00 pm via audio/video. 16 July 2026 - KRM Ayurveda scheduled an investor/analysts group meeting on July 20, 2026 at 4:00 pm via audio/video.
5
Analysts/Institutional Investor Meet/Con. Call Updates
16 July 2026 - Investor/analyst meeting rescheduled to July 21, 2026 at 11:30 am via audio/video. 16 July 2026 - Investor/analyst meeting rescheduled to July 21, 2026 at 11:30 am via audio/video.
Frequently Asked Questions about KRM Ayurveda
Where is KRM Ayurveda (760624) listed?
KRM Ayurveda trades as KRMAYURVED on the NSE.
Which sector does KRM Ayurveda belong to?
KRM Ayurveda is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of KRM Ayurveda?
KRM Ayurveda has a market capitalisation of ₹629.32 Cr, which places it in the Small Cap band.
What is the PE ratio of KRM Ayurveda?
KRM Ayurveda trades at a PE ratio of 0.00, against a book value of ₹56.55 per share.
What is the 52-week high and low of KRM Ayurveda?
Over the last 52 weeks KRM Ayurveda has traded between ₹156.15 and ₹343.95.
What is the Return on Equity (ROE) of KRM Ayurveda?
KRM Ayurveda reported a return on equity of 50.67%. Its debt-to-equity ratio is 1.28.
Company Information
Listed 2026-01-29
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/760624.md for KRM Ayurveda: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.